Teva Pharmaceuticals Inc. made more cuts in the United States, this time to real estate holdings. To save money, the company will close its offices in Washington, D.C. and New York City. No jobs were reported to be lost from the cuts.

Pfizer released an update of the company’s pipeline, including eight different discontinued projects in the field of neuroscience.